Try a new search

Format these results:

Searched for:

in-biosketch:true

person:rosesd01

Total Results:

278


Computerized axial tomography in the diagnosis and management of thyroid and parathyroid disorders [Case Report]

Blum M; Reede DL; Seltzer TF; Burroughs VJ; Greene LW; Roses DF
Computerized axial tomography (CAT) was used to study 39 patients with known thyroid disease and 14 patients with primary hyperparathyroidism. In all, CAT was performed only when information that was required for diagnosis or therapy was not available from other less expensive techniques. The greatest value was found in the evaluation of cryptic symptoms or structures in the neck after surgery for thyroid cancer, the assessment of the extent of thyroid cancer, the localization of aberrant thyroid tissue, the etiology of unexplained recurrent laryngeal nerve paralysis and the identification and delineation of mediastinal goiter. In six of 14 patients undergoing neck exploration for primary hyperparathyroidism CAT correctly localized the site of the enlarged parathyroid glands including one mediastinal parathyroid adenoma and one patient with two parathyroid adenomas
PMID: 6546639
ISSN: 0002-9629
CID: 25107

Prediction of lymph node metastases from the histologic features of primary cutaneous malignant melanomas

Weissmann A; Roses DF; Harris MN; Dubin N
Elective regional lymph-node dissection was performed on 98 patients with clinical Stage I cutaneous malignant melanoma and 26 of them were found to have microscopic evidence of metastases. The histology of the primary lesions was reviewed in order to find possible prognostic parameters that would allow prediction of nodal involvement. There was an increased risk of occult lymph node metastases with increasing thickness of the primary lesions. While this trend was not found to be statistically significant, no occult lymph node metastases were found for lesions less than 1.0 mm in thickness. Significant features included mitotic figures, 'prognostic index,' and plasma cells within the infiltrate. A multiple logistic regression analysis identified three groups of patients with low, medium, and high risk of occult metastases, based on thickness, location, and plasma cells. The correlation between plasma cells and the incidence of metastases in lymph nodes might represent an immunologic phenomenon
PMID: 6528940
ISSN: 0193-1091
CID: 25133

Defining the definitive excision for primary cutaneous malignant melanoma

Roses DF
PMID: 6528905
ISSN: 0193-1091
CID: 25146

Diagnosing and managing common skin cancers

Roses DF; Harris MN; Gumport SL
ORIGINAL:0004234
ISSN: 0025-7583
CID: 25204

Malignant melanoma : how much surgery?

Roses DF
ORIGINAL:0004249
ISSN: 0271-1273
CID: 25243

PHASE-I TRIAL OF SPECIFIC IMMUNOTHERAPY OF MELANOMA WITH A POLYVALENT MELANOMA ANTIGEN VACCINE [Meeting Abstract]

BYSTRYN, JC; LEVIN, M; SPEYER, S; HARRIS, M; ROSES, D; BERNSTEIN, P
ISI:A1984SJ72502565
ISSN: 0009-9279
CID: 40837

Local and in-transit metastases following definitive excision for primary cutaneous malignant melanoma

Roses DF; Harris MN; Rigel D; Carrey Z; Friedman R; Kopf AW
A total of 672 consecutive patients with clinical stage I and stage II primary cutaneous malignant melanoma were treated by excision of 3.0 to 5.0 cm of surrounding skin down to and including the underlying fascia when the lesion exceeded 0.5 mm thickness (Breslow measurement). More conservative margins were taken in locations where such excisions would result in significant cosmetic or functional morbidity and for thinner lesions (less than 0.5 mm). Seven of 658 patients with clinical stage I disease (1.1%) and three of 14 patients with clinical stage II disease (21.4%) developed histologically verified local metastases within 5 cm of the primary excision scar or skin graft. Fifteen patients with stage I disease developed in-transit metastases (2.3%) at a site more than 5.0 cm proximal to the surgical scar or skin graft but not beyond the regional nodal group. Two patients with stage II disease who had developed local metastases also developed in-transit metastases (14.3%). No patient with a lesion less than 1.0 mm thick has had a local recurrence. Nine of the ten patients (90%) who developed local metastases and 12 of the 17 patients (70.6%) who developed in-transit metastases have also developed systemic metastases to date. Local and in-transit metastases following such definitive excision is a significant indicator of disseminated systemic metastatic melanoma
PMCID:1352934
PMID: 6859994
ISSN: 0003-4932
CID: 25134

Predictors of late deaths among patients with clinical stage I melanoma who have not had bony or visceral metastases within the first 5 years after diagnosis

Day CL; Mihm MC; Sober AJ; Harris MN; Kopf AW; Fitzpatrick TB; Lew RA; Harrist TJ; Golomb FM; Postel A; Hennessey P; Gumport SL; Raker JW; Malt RA; Cosimi AB; Wood WC; Roses DF; Gorstein F; Rigel D; Friedman RJ; Mintzis MM
PMID: 6863649
ISSN: 0190-9622
CID: 16625

Favorable prognosis for malignant melanomas associated with acquired melanocytic nevi

Friedman RJ; Rigel DS; Kopf AW; Lieblich L; Lew R; Harris MN; Roses DF; Gumport SL; Ragaz A; Waldo E; Levine J; Levenstein M; Koenig R; Bart RS; Trau H
In a clinicohistopathologic study of 557 patients with primary cutaneous malignant melanoma, there were fewer metastases and/or deaths from melanoma when histologic evidence of a coexisting acquired melanocytic nevus was found. A total of 130 patients with melanocytic nevus and 427 cases of melanoma without histologic evidence of a nevus (denovo) were studied. Clinical follow-up evaluation for evidence of metastases and/or death was obtained. Only ten of the patients (7.7%) with nevus-associated melanoma had metastases and/or death v 78 (18.3%) with de novo melanoma. When stratified by lesion thickness, the logrank test for survival revealed a statistically significant difference between the two groups. An overall favorable outcome seen in patients with malignant melanomas associated with acquired melanocytic nevi was found, therefore, to be independent of lesion thickness as well as six other variables reported to be related to the biologic behavior of malignant melanoma. Thus, the presence of nevus cells in a specimen of malignant melanoma portends a better prognosis and may have important implications in the biology of this neoplasm
PMID: 6859885
ISSN: 0003-987x
CID: 16858

Carcinoma of the thyroglossal duct [Case Report]

Roses DF; Snively SL; Phelps RG; Cohen N; Blum M
Seven patients with carcinoma in a thyroglossal duct cyst have received treatment over a 15 year period. Findings in all of these patients reflect the likelihood of carcinoma arising within thyroglossal duct tissue. In each patient there was sufficient histologic evidence of the presence of a thyroglossal duct cyst and carcinoma arising within an intimate admixture of normal thyroid tissue in the cyst wall. In the absence of a history of irradiation and with separation of the carcinoma from the pyramidal lobe of the thyroid, excision of the thyroglossal cyst alone by traditional means seems appropriate. Our experience as well as a review of reported cases to date indicate that distant metastases are extremely rare and the prognosis excellent
PMID: 6824140
ISSN: 0002-9610
CID: 25108